ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ELAB Company Profile and Key Details

NASDAQ : ELAB

Elevai Labs, Inc. Common Stock

$3.92

-0.19-462.30%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

ELAB Stock Price Chart

Stock Price Today

Elevai Labs, Inc. Common Stock (ELAB) stock declined over -462.29%, trading at $3.92 on NASDAQ, down from the previous close of $4.11. The stock opened at $4.11, fluctuating between $3.92 and $4.49 in the recent session.

Stock Snapshot

4.11

Prev. Close

4.11

Open

2.26M

Market Cap

577.47K

Number of Shares

3.92

Day Low

4.49

Day High

-0.01

P/E Ratio

100%

Free Float in %

-622.43

EPS (TTM)

N/A

Book Value

N/A

Cash Flow per Share

73.01K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 13, 2025	4.11	4.50	3.91	3.92	73.17K
Mar 12, 2025	4.71	4.82	3.88	4.11	75.89K
Mar 11, 2025	5.05	5.39	4.62	4.71	102.89K
Mar 10, 2025	4.68	6.03	4.41	5.16	158.2K
Mar 07, 2025	4.62	5.32	4.39	5.04	78.99K
Mar 06, 2025	6.22	6.22	4.58	5.06	215.17K
Mar 05, 2025	8.26	8.75	8.19	8.61	13.27K
Mar 04, 2025	8.12	8.47	7.98	8.40	18.9K
Mar 03, 2025	9.03	9.24	8.40	8.47	15.02K
Feb 28, 2025	8.40	9.10	8.33	8.75	36.37K
Feb 27, 2025	8.89	8.96	8.26	8.33	25.81K
Feb 26, 2025	8.40	9.31	8.26	8.75	43.49K
Feb 25, 2025	9.17	9.59	8.12	8.47	60.7K
Feb 24, 2025	11.41	11.69	10.71	10.99	37.44K
Feb 21, 2025	11.48	11.97	11.20	11.55	52.58K
Feb 20, 2025	11.83	11.90	11.34	11.41	25.8K
Feb 19, 2025	11.62	12.18	11.62	11.90	33.6K
Feb 18, 2025	12.18	12.25	11.62	11.62	49.66K
Feb 14, 2025	11.83	12.25	11.76	11.90	23.19K
Feb 13, 2025	11.90	12.32	11.76	11.90	32.15K

Contact Details

United States

Website: No DataContact: 0

About Company

Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.

Frequently Asked Questions

What is the current Elevai Labs, Inc. Common Stock (ELAB) stock price?

Elevai Labs, Inc. Common Stock (NASDAQ: ELAB) stock price is $3.92 in the last trading session. During the trading session, ELAB stock reached the peak price of $4.49 while $3.92 was the lowest point it dropped to. The percentage change in ELAB stock occurred in the recent session was -4.62% while the dollar amount for the price change in ELAB stock was -$0.19.

ELAB's industry and sector of operation?

The NASDAQ listed ELAB is part of Biotechnology industry that operates in the broader Healthcare sector. Elevai Labs, Inc. Common Stock designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ELAB?

No Data

How ELAB did perform over past 52-week?

ELAB's closing price is 1.03% higher than its 52-week low of $3.88 where as its distance from 52-week high of $1,134.00 is -99.65%.

How many employees does ELAB have?

Number of ELAB employees currently stands at 18.

Link for ELAB official website?

Official Website of ELAB is:

How do I contact ELAB?

ELAB could be contacted at phone 0 and can also be accessed through its website. ELAB operates from , , , United States.

How many shares of ELAB are traded daily?

ELAB stock volume for the day was 73.01K shares. The average number of ELAB shares traded daily for last 3 months was 314.33K.

What is the market cap of ELAB currently?

The market value of ELAB currently stands at $2.26M with its latest stock price at $3.92 and 577.47K of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	18
Beta	-2.99
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology